Jeffrey C. Xing

681 citations
14 papers · 350 indexed · h-index 9
Topics
Chronic Lymphocytic Leukemia Research (6 papers)Lymphoma Diagnosis and Treatment (4 papers)Thyroid Cancer Diagnosis and Treatment (3 papers)
Partner nations
United StatesChina

In The Last Decade

Jeffrey C. Xing

14 papers receiving 343 citations

Peers

Jeffrey C. Xing
Comparison fields: 5 of 46
  • Molecular Biology 177
  • Pathology and Forensic Medicine 102
  • Endocrinology, Diabetes and Metabolism 100
  • Genetics 83
  • Oncology 78
Replace Luigi Alfano with:
Luigi Alfano Italy
P. Buhl-Jensen United Kingdom
Zita Dubauskas United States
Betelehem W. Yacob United States
Jaime Miguel Gomes Pita Belgium
Anna Ma United States
Flavia Barbi Italy
Kyoei Morozumi Japan
Janine Schwamb Germany
C Mitsiades United States
Jeffrey C. Xing relative to Luigi Alfano Italy Luigi Alfano's profile →
Citations per field
00.5×5.6×
Luigi Alfano · 1×
Citations per year

Countries citing papers authored by Jeffrey C. Xing

Since Specialization
Citations

This map shows the geographic impact of Jeffrey C. Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey C. Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey C. Xing more than expected).

Fields of papers citing papers by Jeffrey C. Xing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey C. Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey C. Xing. The network helps show where Jeffrey C. Xing may publish in the future.

Co-authorship network of co-authors of Jeffrey C. Xing

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey C. Xing. A scholar is included among the top collaborators of Jeffrey C. Xing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey C. Xing. Jeffrey C. Xing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 37
2 33
3 2
4 1
5 24
6 11
7 8
8 1
9 24
10 48
11 16
12 3
13 38
14 104

About Jeffrey C. Xing

Jeffrey C. Xing is a scholar working on Genetics, Pathology and Forensic Medicine and Endocrinology, having authored 14 papers that have together received 350 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (6 papers), Lymphoma Diagnosis and Treatment (4 papers) and Thyroid Cancer Diagnosis and Treatment (3 papers). The work is most often cited by research in Genetics (83 citations), Endocrinology, Diabetes and Metabolism (100 citations) and Pathology and Forensic Medicine (102 citations). Jeffrey C. Xing has collaborated with scholars based in United States and China. Frequent co-authors include Mingzhao Xing, Barry Trink, О. С. Ларін, Guojun Wu, Vasily Vasko, Shuiying Hu, В. Н. Савченко, Thomas P. Loughran, David J. Feith and Chunhua Lü. Their work appears in journals such as Science, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026